Saratov JOURNAL of Medical and Scientific Research

Evidence of the safe period intravitreal tamponade by perfluorodecalin in clinical practice

Year: 2018, volume 14 Issue: №4 Pages: 862-866
Heading: Ophtalmology Article type: Original article
Authors: Arslanov G.M., Aznabaev В.М., Mukhamadeev T.R., Dibaev T.I.
Organization: Saratov State Medical University, The Eye Clinic «Zrenie» (Saint Petersburg)

 Purpose: to perform clinical testing of perfluorocarbon liquid on the basis of perfluorodecalin with the possibility of intravitreal postoperative tamponade in patients with vitreoretinal pathology and explain the effectiveness of this practice. Material and Methods. Were evaluated anatomical and clinical results of vitrectomy with PFCL intravitreal tamponade in 105 (113 eyes) patients with severe vitreoretinal pathology. Three observation groups were distinguished: group I (in-traoperative and postoperative intravitreal tamponade by perfluorodecalin, national sample); group II (only intraopera-tive use of perfluorodecalin, foreign sample); group III (only intraoperative use of perfluoro-1.3- dimethylcyclohexane). Results. Retinal attachment in the group of patients with postoperative intravitreal tamponade was 97.1% (visual acuity increased in 71.5% cases). All cases of failure or redetachment, postoperative complications and cataract progression did not have a statistically significant association with postoperative intravitreal tamponade as risk factor (x2=0,316; X2=0,068; x2=0.061; x2=0.403, p>0.05). Conclusion. Clinical testing of perfluorocarbon liquid intravitreal tamponade on the basis of perfluorodecalin in patients with vitreoretinal pathology showed high anatomical and clinical results with a high probability of retinal attachment.

1 Haidt SJ, Clark LC, Ginsberg J. Liquid perfluorocarbon replacement in the eye. Investigative Ophthalmology & Visual Science 1982; (22): 233
2 Shishkin MM, Danilichev VF, Kulikov AN, et al. Perfluorocarbon compounds in combined surgery of anterior proliferative vitreoretinopathy. In: Perfluororganic compounds in biology and medicine. Pushchino, 1997; p. 215-9
3 Rizzo S, Barca F. Vitreous substitute and tamponade substances for microincision vitreoretinal surgery. Dev Ophthalmol 2014; 54: 92-101
4 Kazaykin VN. Vitreal cavity tamponade with liquid vitreous substitutes in surgery for giant retinal gaps: PhD diss: Ekaterinburg, 2000; 199 c.
5 Boyko EV, Kulikov AN, Churashov SV, et al. Comparative evaluation of the use of domestic perfluorooctyl bromide and perfluorodecalin in vitreoretinal surgery of the effects of open eye injury. Bulletin of the Russian Military Medical Academy 2007; 3 (19): 77-80
6 Figueroa MS, Casas DR. Inflammation Induced by Perfluorocarbon Liquid: Intra- and Postoperative Use. Biomed Res Int 2014; 907816: 8
7 Orlov GD, Saraev V.A. Fluorine compounds. In: Chemistry, technology, application. RNTs «Prikladnaya khimiya», 2009; 41
8 Osipov АР, Gorshkov YuV, Lyubimov AN. Features of the combined use of carbogal and perfluorodecalin in the treatment of burns. Medline 2004; (5): 200-1
9 Aznabaev ВМ, Mukhamadeev TR, Yanbukhtina ZR, et al. Investigation of the effect of perfluororganic compounds on the processes of free-radical oxidation in a model system. Medical Bulletin of Bashkortostan 2015; 10 (2): 119-21
10 Arslanov GM, Mukhamadeev TR, Aznabaev BM, et al. Electroretinographic studies after vitrectomy with tamponade by perfluororganic compounds in rabbits. Vrach-aspirant 2015; 71 (4.1): 132-8
11 Aznabaev ВМ, Arslanov GM, Dibaev Tl, et al. Histological changes in the retina of rabbits with intravitreal tamponade by perfluororganic compounds. Cataract and refractive surgery 2016; 16 (1): 57-61
12 Arslanov GM, Mukhamadeev TR, Yanbukhtina ZR, et al. Electron-microscopic changes in the retina of rabbits with intravitreal tamponade by perfluororganic compounds. Medical Bulletin of Bashkortostan 2017; 122): 49-52
13 Shkvorchenko DO. Comprehensive surgical treatment of retinal detachments, complicated by giant tears and tears from the dentate line, using liquid perfluororganic compounds: PhD dissertation: M., 1995; 131 p.
14 Kulikov AN. Experimental study of high-purity organofluorine compounds with intravitreal administration: PhD diss. SPb., 1997; 153 p.
15 Flores-Aguilar М. Intraocular tolerance of perfluorooctylbromide (perflubron). Retina 1995; 15 (1): 3-13
16 Peyman GA. Intravitreal tolerance of a new perfluorocarbon vitreous replacement, MultifluorAPF-144. Can J Ophthalmol 1996; 31 (7): 345-9
17 Stolba U, Krepler K, Pflug R, et al. Experimental vitreous and aqueous replacement with perfluorophenanthrene: Clinical, histologic, and electrophysiologic results. Retina 1997; 17(2): 146-53
18 Liang C, Peyman GA. Tolerance of extended-term vitreous replacement with perfluoro-n-octane and perfluoroperhydrophenanthrene mixture (phenoctane). Retina 1999; 19(3): 230-7
19 Zeana D. Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. International Ophthalmology 1999; 23 (1): 17-24
20 Mackiewicz J. Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes. Graefe's Archive for Clinical and Experimental Ophthalmology 2007; 245 (5): 665-75
21 Stolba U, Krepler K, Pflug R, et al. Experimental vitreous and aqueous replacement with perfluorophenanthrene: Clinical, histologic, and electrophysiologic results. Retina 1997; 17(2): 146-53
22 Yu Q. Perfluorocarbon liquid: its application in vitreoretinal surgery and related ocular inflammation. Biomed Res Int 2014; (250323): 6
23 Serezhin IN. Sparing vitreoretinal technologies in the restorative treatment of diseases and injuries of the posterior part of the eye: DSc diss. SPb., 2007; 264 p.
24 Randolph JC, Diaz R, Sigler EJ. 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears. Graefe's Arch Clin Exp Ophthalmol 2015; (12)
25 Barthelmes D, Chandra J. Perfluoro-n-octane as a temporary intraocular tamponade in a staged approach to manage complex retinal detachments. Clin Ophthalmol 2015; 27 (9): 413-8.

2018_4-2_862-866.pdf264.27 KB

No votes yet